Your browser doesn't support javascript.
loading
Debating Deposits, Redux: Substantial Interobserver Agreement Exists in Distinguishing Tumor Deposits From Nodal Metastases in Small Bowel Neuroendocrine Tumors.
Gonzalez, Raul S; La Rosa, Stefano; Ma, Changqing; Polydorides, Alexandros D; Shi, Chanjuan; Yang, Zhaohai; Cox, Brian; Karamchandani, Dipti M.
Afiliação
  • Gonzalez RS; From the Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, Georgia (Gonzalez).
  • La Rosa S; Unit of Pathology, Department of Medicine and Surgery, University of Insubria, Varese, Italy (La Rosa).
  • Ma C; Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri (Ma).
  • Polydorides AD; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York (Polydorides).
  • Shi C; Department of Pathology, Duke University Medical Center, Durham, North Carolina (Shi).
  • Yang Z; Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia (Yang).
  • Cox B; Pacific Rim Pathology, San Diego, California (Cox).
  • Karamchandani DM; and the Department of Pathology, UT Southwestern Medical Center, Dallas, Texas (Karamchandani).
Arch Pathol Lab Med ; 2023 Aug 28.
Article em En | MEDLINE | ID: mdl-37639446
ABSTRACT
CONTEXT.­ Recent data suggest mesenteric tumor deposits (MTDs) indicate poor prognosis in small bowel well-differentiated neuroendocrine tumors (SB-NETs), including compared to positive lymph nodes, making their distinction crucial. OBJECTIVE.­ To study interobserver agreement in distinguishing SB-NET MTDs from positive nodes. DESIGN.­ Virtual slides from 36 locally metastatic SB-NET foci were shared among 7 gastrointestinal pathologists, who interpreted each as an MTD or a positive node. Observers ranked their 5 preferred choices among a supplied list of potentially useful histologic features, for both options. Diagnostic opinions were compared using Fleiss multirater and Cohen weighted κ analyses. RESULTS.­ Preferred criteria for MTD included irregular shape (n = 7, top choice for 5), perineural invasion/nerve entrapment (n = 7, top choice for 2), encased thick-walled vessels (n = 7), and prominent fibrosis (n = 6). Preferred criteria for positive nodes included peripheral lymphoid follicles (n = 6, top choice for 4), round shape (n = 7, top choice for 2), peripheral lymphocyte rim (n = 7, top choice for 1), subcapsular sinuses (n = 7), and a capsule (n = 6). Among 36 foci, 10 (28%) each were unanimously diagnosed as MTD or positive node. For 13 foci (36%), there was a diagnosis favored by most observers (5 or 6 of 7) positive node in 8, MTD in 5. Only 3 cases (8%) had a near-even (43) split. Overall agreement was substantial (κ = .64, P < .001). CONCLUSIONS.­ Substantial interobserver agreement exists for distinguishing SB-NET MTDs from lymph node metastases. Favored histologic criteria in making the distinction include irregular shape and nerve/vessel entrapment for MTD, and peripheral lymphocytes/lymphoid follicles and round shape for positive nodes.

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article